INTRODUCTION
Chronic wasting disease (CWD) is a fatal transmissible spongiform encephalopathy (TSE) of cervids, including deer, elk and moose. CWD is the only TSE found in free-ranging wildlife; its spread in nature may reflect the dissemination of prions from saliva and excreta of infected cervids (10, 20, 22, 28, 36) and/or the persistence of infectious prions in the environment (15, 23, 30) . While the known natural host range for CWD is limited to cervids, recent studies have expanded the number of non-cervid species (ferrets, mink, hamsters, cattle, sheep, Peromyscus spp. mice and voles) that can be infected experimentally (3, 11-14, 26, 32) . It is not known whether non-cervid species may contribute to the spread of CWD as reservoirs or vectors, however, inter-species transmission of prion diseases (e.g. from deer to non-cervids) is less efficient than intraspecies transmission, a phenomenon commonly referred to as a species barrier. Species barriers may be mediated by differences in PrP C sequence (5, 13, 16), inoculum titer, route of inoculation, and other still unknown factors (4, 13, 16, 24, 25) .
We recently demonstrated (18) that PrP C from several non-cervid species, including prairie voles (Microtus ochrogaster) and prairie deer mice (Peromyscus maniculatus bairdii), can be converted to PrP RES in vitro by serial protein misfolding cyclic amplification (sPMCA). Heisey et al. (14) have since shown that other vole and
Peromyscus species are indeed susceptible to intracerebral inoculation CWD. To determine whether sPMCA may enhance inter-species TSE transmission, we inoculated prairie voles (Microtus ochrogaster) with sPMCA products consisting of deer PrP RES amplified in normal vole brain vs. brain homogenate from a CWD-infected deer not subjected to sPMCA. Our studies suggest that sPMCA can facilitate the transmission of CWD to non-cervid species and thereby may be useful in assessing species barriers to CWD infection.
MATERIALS AND METHODS
Sources and preparation of brain homogenates for sPMCA. Donor animals were housed and euthanized according to IACUC approved protocols. Tg(CerPrP)1536 +/-mice (5) were housed at Colorado State University (CSU). Prairie voles (Microtus ochrogaster) were obtained from Thomas Curtis (University of Oklahoma) and were housed at CSU. Normal brain homogenates (NBH) were prepared as previously described (17). CWD-positive brain homogenate D10 was prepared from a CWDinfected mule deer (generously provided by Michael Miller, Colorado Division of Wildlife) and has been used previously in several CWD bioassay and sPMCA studies (5, 17, 20, 21) . sPMCA procedure. To prevent possible contamination, NBH was thawed on ice and loaded into 96 well plates (TempPlate III, USA Scientific) or 0.2 ml PCR tubes (Nunc/ThermoFisher Scientific) in a laboratory that was never used for prion research.
The samples were then transported to the prion research laboratory where CWD-positive brain homogenate was diluted into the NBH to comprise a total volume of 50 μl (unseeded, NBH-only controls also comprised 50 μl). Equivalent dilutions not subjected to sPMCA were frozen at -70 o C for the duration of the experiment and used for quantification of amplified samples. The samples were placed in a Misonix 4000 sonicator containing 200 mL distilled water and subjected to 40 s bursts at power level 7
followed by 30 min incubations at 37 o C for 48 hr (this comprising 1 round of PMCA), paraffin. Paraffin-embedded sections (6 μm) were mounted onto positively charged glass slides and then heated at 65 0 C for 45 min, de-paraffinized, and rehydrated through graded ethanol. Antigen retrieval was performed using a Retriever™ system and DAKO Target Retrieval Solution (DAKO, Hamburg, Germany). Tissues were blocked in 3%
hydrogen peroxide in methanol for 1 hr followed by TNB buffer (Perkin-Elmer) for 1 hr.
Tg1536 mouse tissues were stained for PrP using HRP-conjugated monoclonal antibody or coyote brain homogenate were brought to a final SDS concentration of 0.25% prior to digestion with 100 μg/mL proteinase K (PK) for 30 min at 37 o C followed by 10 min at 45 o C. Vole samples were digested with 100 μg/mL PK for 30 min at 37 o C unless otherwise noted. The different PK digestion protocols were developed to address the innate differences in PK sensitivity of PrP C between different species (18). Samples had a final volume of 10 μl after addition of PK, and were boiled in 0.33% NLS buffer (Invitrogen) for 3 minutes after PK digestion.
Electrophoresis and western blotting of sPMCA samples was performed as previously described (17, 18) . After transfer, membranes were incubated in blocking solution (0.5% nonfat dry milk in PBS with .05% Tween-20) and antibodies using the Millipore SNAP-i.d. system. Membranes for evaluation of Tg1536 mouse, vole, mink, cat and coyote samples were incubated in Bar224 mAb (Cayman Chemical) conjugated directly to horse radish peroxidase (HRP), except where noted. All membranes were washed using dH 2 0 containing 0.2% Tween-20 before application of ECL-plus™ chemiluminescent reagents (Amersham). Data were generated using a digital Fuji-Doc™ gel documentation system (Fuji) with automated detection of saturation limits, and densitometric analyses were performed using ImageGauge (Fuji) and Photoshop (Adobe)
programs.
Proteinase K degradation and glycoform analyses. For proteinase K (PK) degradation assays, 8 μl samples of 10% brain homogenate were digested with 500, 1000, 2000 and 4000 μg/ml proteinase K (PK) at 37 o C for 30 min. The size and density of the protease-resistant western blot bands that resulted were measured using the Photoshop (Adobe) histogram function and these values were plotted using Excel (Microsoft). A linear trend line was fit to the data and used to calculate the concentration of PK that would result in 50% of the signal intensity (PK 50 ) of the most intense sample (i.e. the one digested with 500 μg/ml PK). Four experiments were used to find the average PK 50 for each prion isolate. Outliers were defined as any PK 50 value that differed from the others for that prion isolate by greater than 1000 μg/ml. The results were then compared using two-tailed t-tests with α = 0.05. correspond to a ~1:6000 dilution of D10 with respect to the PrP RES in D10. These vPMCA-voles were euthanized by 239 ± 17 dpi due to signs of neurologic disease (Table   1 ). This survival period compares with that produced by IC inoculation of Tg(CerPrP) 1536 mice with a 1:500 dilution of D10 (greater than 1000-fold the D10 concentration and greater than 10-fold the PrP RES present in the inocula received by the vPMCA voles), in which all animals became symptomatic and were euthanized by 259 ± 20 dpi (Table   1) .
Glycoform ratios and migration patterns. No differences in glycoform ratio between
the vPMCA-voles and CWD-voles were noted. PrP RES from vPMCA-voles displayed a significantly higher proportion of the diglycosylated (p = 0.0002, two-tailed t-test), and less of the mono-(p = 0.004, two-tailed t-test) and unglycosylated (p = 0.0002, two-tailed t-test) PrP RES forms than CWD-infected deer brain (not shown). The final concentration of D10 in the vPMCA-Product was 1.5 x 10 -6 after 3 rounds of sPMCA. Control animals were orally inoculated with unseeded NBH from the same PMCA experiment and with deer brain from a CWD-negative deer. No control animals developed clinical signs of neurologic disease nor were any of these animals positive for PrP RES by WB after 600-700+ dpi. Furthermore, none of the animals inoculated orally with 1:100 D10 CWD+ deer brain were positive after 500+ dpi (Table 1) . Three animals in this group were observed for 833 dpi and did not show clinical signs of neurologic disease or PrP RES by WB.
In contrast, the brains of 5 of 9 (Table 1) animals orally inoculated with PrP RES generated by amplification of D10 in prairie vole NBH, a final D10 dilution of 1.5 x 10 -6 , were positive for PrP RES by WB. One of these animals showed clinical signs of neurologic disease including lethargy and hindlimb paresis and was euthanized at 462 dpi (animal 2266, Fig.9 ). A second animal showed clinical signs and was euthanized at 646 dpi (animal 2269, Fig.9 ). The last animal to show clinical signs was euthanized at 735 dpi, at which point any remaining animals were also euthanized and analyzed by WB.
DISCUSSION
In the present study we demonstrate that PrP RES generated in vitro by transspecies sPMCA is infectious. Prairie voles are an outbred species with the probability of exposure to CWD in nature. All nine voles inoculated with sPMCA-generated prions, nominally equivalent to a 1:512,000 dilution of the initial mule deer brain D10 substrate from hamsters, and vice versa, and that this was followed by enhanced transmission to the species used for substrate. Similarly, Green et al. (9) demonstrated that amplification of mouse scrapie in NBH from Tg(CerPrP)1536 mice generated prions were transmissible to Tg(CerPrP)1536 mice. Our studies reinforce these findings using CWD prions and prairie voles, an out-bred species whose geographic range overlaps that of CWD-infected cervids and thereby may be exposed to CWD prions in nature (2, 38).
Importantly, our results suggest that if prairie voles or other rodent species become naturally infected with CWD, the resultant oral infectivity may be enhanced for that species. Lanes 2-4 show 1:400, 1:800 and 1:1600 dilutions of D10 not subjected to PMCA ("-"), respectively. Dilutions of D10 greater than 1:10,000 are not detectable by western blot. Lane 1 is 1/10 the volume of D10 brain not subjected to PMCA or PK digestion. Lane 6 is unseeded vole NBH after PMCA and PK digestion. This panel is representative of three independent experiments. B: Infected voles displayed signs of neurological disease including frequently rolling into dorsal recumbency (animal in upper left). C: All nine voles ("vPMCAvoles") inoculated with PrP RES generated by trans-species PMCA ("vPMCA-Product" from 2A) were positive for PrP RES by western blot (Lanes 4-12). Lanes 1-2 (marked "Deer") indicate samples from CWD-infected deer D10 for comparison. Lanes 13-14 (marked "NBH voles") consist of brain homogenate from voles inoculated with unseeded, NBH-only samples from the PMCA experiment shown in 2A. These samples were subjected to same PK conditions, and were present on the same blot (but separated by additional lanes). voles") were subjected to digestion with 500 -4000 μg/ml proteinase K (PK). The PK degradation assay was repeated at least four times for each isolate. The results were plotted on a graph (below each blot) and average PK concentration required to decrease the western blot signal by half, relative to the 500 μg/ml lane, was found using the linear regression lines (given as a whole numeral under each representative western blot).
Fig. 7. PrP
RES from infected voles amplifies in cat, coyote and mink normal brain homogenate (NBH) by trans-species PMCA. CWD-positive deer brain D10 (PrP RES source "Deer") and pooled brain homogenate from vPMCA-voles were diluted 1:100 into cat (A), coyote (B) and mink (C) NBH. 2-3 replicate samples were subjected to PK digestion ("PK+") after 3 rounds of PMCA ("PMCA+"). The final dilution of each sample was 1:400, represented by a non-amplified ("PMCA -") 1:400 dilution for reference (lanes 2 and 7 in panels A and B, lanes 1 and 5 for C). Unseeded NBH subjected to 3 rounds of PMCA followed by PK digestion ("NBH") comprises lanes 4-5 and 10-11 in panels A and B, and lanes 9-11 in C. Samples not digested with PK ("PK -") demonstrate PrP C present in the NBH. Results are representative of 3 experiments. . A: CWD-positive deer brain D10 ("Deer brain homog.") and pooled brain homogenate from vPMCA-voles were diluted 1:100 into red-backed vole (Myodes gapperi) NBH. 2 replicate samples were subjected to 3 rounds of PMCA ("PMCA +") followed by PK digestion ("PK +"). The final dilution of each sample was 1:400, represented by a nonamplified ("PMCA -") 1:400 dilution for reference (lane 2). Unseeded NBH subjected to 3 rounds of PMCA followed by PK digestion ("NBH") comprises lanes 11-12. Samples not digested with PK ("PK -", lane 1) demonstrate PrP C present in the NBH. Results are representative of 3 experiments. B: Average densitometric scores (arbitrary units) from part A were plotted on a graph. Results from experiments using vPMCA-vole brain as seed are represented by triangles and a solid linear regression line, and experiments using deer brain as seed are represented by circles and a dashed linear regression line. Nine prairie voles (animal numbers 2266-2275) were inoculated with 35 μl of brain homogenate produced by cyclic amplification of D10 CWD+ deer brain in vole NBH ("vPMCAProduct"). The final dilution of D10 in the inoculum was 1.5 x 10 -6 . Animal 2266 showed clinical signs and was euthanized at 462 dpi, animal 2269 showed clinical signs and was euthanized at 646 dpi. The others were euthanize by 735 dpi. Animals 2267 and 2270 showed evidence of PrP RES on immunoblots that were markedly overexposed (not shown). Brain samples were subjected to 25 μg/ml PK digestion, except the lane 12, which shows vole PrP C . All samples contained a total volume of 20 μl of 10% brain homogenate, except Lanes 1-2 and Lane 10, which contained 1/10 that volume. Table 1 . Attack rates and incubation periods (± standard deviation). ^The attack rate is 5/6 if two voles that died before 200 dpi are excluded from the analysis. *This incubation period was significantly different from the "CWD-voles" (p < 0.05) and from Tg1536 mice (p < 0.05).
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